KANDRA DODD: Open Payments
NPI 1003393778 · MCALESTER, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 48 payments from 12 companies in 2025. Trend: 2023 $94 · 2024 $253 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $218 |
| ABBVIE INC. | 14 | $165 |
| Lilly USA, LLC | 3 | $56 |
| Ardelyx, Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| PFIZER INC. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: Wegovy, VRAYLAR, Ozempic, IBSRELA, REXULTI, NURTEC ODT, QULIPTA, TRINTELLIX.
Industry payments across OK — which companies pay providers there.
